Liquid chromatography-mass spectrometry-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated with the progression of nonalcoholic fatty liver disease.

Liquid chromatography-mass spectrometry-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated with the progression of nonalcoholic fatty liver disease.

Item

http://www.wikidata.org/entity/Q34103693

Q34103693

about

Metabolomic analysis of human cirrhosis, hepatocellular carcinoma, non-alcoholic fatty liver disease and non-alcoholic steatohepatitis diseases Metabonomic window into hepatitis B virus-related hepatic diseases Nonalcoholic fatty liver disease: update on pathogenesis, diagnosis, treatment and the role of S-adenosylmethionine Obesity and psychotic disorders: uncovering common mechanisms through metabolomics Controlling complexity: the clinical relevance of mouse complex genetics A metabolomic analysis of omega-3 fatty acid-mediated attenuation of western diet-induced nonalcoholic steatohepatitis in LDLR-/- mice Lipocalin 2 (LCN2) Expression in Hepatic Malfunction and Therapy Biomarkers in nonalcoholic fatty liver disease A (1)H NMR-Based Metabonomic Investigation of Time-Related Metabolic Trajectories of the Plasma, Urine and Liver Extracts of Hyperlipidemic Hamsters Transient and persistent metabolomic changes in plasma following chronic cigarette smoke exposure in a mouse model Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver disease Urinary metabolomics analysis identifies key biomarkers of different stages of nonalcoholic fatty liver disease The metabolomic window into hepatobiliary disease.Metabolomic similarities between bronchoalveolar lavage fluid and plasma in humans and mice Systems biology for hepatologists.Glycine N-methyltransferase deficiency affects Niemann-Pick type C2 protein stability and regulates hepatic cholesterol homeostasis.S-adenosylmethionine in liver health, injury, and cancer.Plasma metabolomics identifies lipid abnormalities linked to markers of inflammation, microbial translocation, and hepatic function in HIV patients receiving protease inhibitors.Estimation of psychological stress in humans: a combination of theory and practice Diagnosing fatty liver disease: a comparative evaluation of metabolic markers, phenotypes, genotypes and established biomarkers.Biomarkers of NAFLD progression: a lipidomics approach to an epidemic.Proteomic profiling of adipose tissue from Zmpste24-/- mice, a model of lipodystrophy and premature aging, reveals major changes in mitochondrial function and vimentin processing.The promise of metabolic phenotyping in gastroenterology and hepatology.Metabolomic profiles of hepatocellular carcinoma in a European prospective cohort.Obesity-dependent metabolic signatures associated with nonalcoholic fatty liver disease progression Metabolomic applications to decipher gut microbial metabolic influence in health and disease Inhibition of natural killer cells protects the liver against acute injury in the absence of glycine N-methyltransferase.Metabolomic analysis of the effects of polychlorinated biphenyls in nonalcoholic fatty liver disease.Combined effects of a high-fat diet and chronic valproic acid treatment on hepatic steatosis and hepatotoxicity in rats.Serum UPLC-MS/MS metabolic profiling in an experimental model for acute-liver injury reveals potential biomarkers for hepatotoxicity.Biomarkers in liver disease: emerging methods and potential applications A metabolic signature predicts biological age in mice.Clinical metabolomics paves the way towards future healthcare strategies.Analysis of Therapeutic Effect of Ilex hainanensis Merr. Extract on Nonalcoholic Fatty Liver Disease through Urine Metabolite Profiling by Ultraperformance Liquid Chromatography/Quadrupole Time of Flight Mass Spectrometry.Metabolomic Study on Idiosyncratic Liver Injury Induced by Different Extracts of Polygonum multiflorum in Rats Integrated with Pattern Recognition and Enriched Pathways Analysis Metabolomic signatures associated with disease severity in multiple sclerosis Metabonomics Research Progress on Liver Diseases.Ultra-performance liquid chromatography coupled to mass spectrometry as a sensitive and powerful technology for metabolomic studies.Modern analytical techniques in metabolomics analysis.Plant-based foods as a source of lipotropes for human nutrition: a survey of in vivo studies.

P2860

Q26741550-889EDB24-792C-428B-B5C6-397901C9E0F2 Q26771253-032B4E9B-7206-4A0A-AC91-C9332FD817E3 Q26992163-874DF581-675B-4BDC-B648-8DE7877629F5 Q27011617-D335DCDF-EA19-40EC-B02C-303336B64217 Q27027931-83C7CC91-879B-446D-8C3B-EAA57AB527E9 Q27339224-6F573CC9-E6D6-4E41-94DA-AA305CCA2042 Q28068137-B1AC88B4-7AC8-45AC-A712-E13592D45971 Q28080541-BE7E4697-DDE3-427C-8313-2544CD787CA8 Q28534338-7C0F253E-FF5C-4516-BC01-E933840CDA5C Q28540580-F1C0B5CB-9FE7-4B82-90F5-F25ADE6D0616 Q30376231-653AB1CC-58AA-436D-A8DA-DF5A12E3AD63 Q33599564-EC74932E-3FAF-4617-980F-AD7CFA137CF8 Q33893457-DFE0356F-D5AA-4330-97CE-6B4BEC56C731 Q33894887-95FF182B-D179-4C38-AEA1-54ED400CCFA2 Q33927426-39DBB71E-34FB-42B2-9050-EFA9F569E392 Q34241720-E7C873E3-604B-4ED8-ACE6-985E523BD496 Q34306534-395559C6-EB70-4D2A-BF4A-DD7A41A57260 Q34704820-61739B9F-7857-4FF7-A4CC-87FC9F3C96EA Q34729993-5BBCB0C9-D2F4-4820-87E0-AE5F8D9DBA31 Q35018573-85DB7737-E7FC-4F65-9C0F-7079ED9F7B1E Q35120968-488EF2C6-4D82-4F0E-8B57-BEF42D867350 Q35579609-9A6C16E8-9486-4FAB-9829-00E4A958BEF8 Q35701279-6FB94796-2619-431C-91D0-9A8C9456D90A Q35785514-91252638-7C37-48DF-A53D-2AA561CB039B Q35874842-EF1A9016-C5EB-4099-9DAE-9B435021835C Q35914935-8E1A76E8-AB5A-4BCF-9B20-0B66DC54EDD6 Q36044222-32405BEE-D5CB-4817-A26C-2BBB3E09351F Q36080956-8D5AFC41-0E8C-4125-A082-C65CAC02F380 Q36287433-B9F416D2-35AC-4BFD-8319-E9A6B447897E Q36375764-76C37B63-0DA1-4201-81D1-4C313814914D Q36413685-161C83FA-3539-44A9-AD44-500497A08FCC Q36553679-42C8B9CD-F7CA-4612-B1C4-2810E1F70B36 Q36620171-0502F19A-5588-416A-8A8F-18EB34F1D539 Q37166645-80FF6E0C-3779-4796-8034-1FC3F89AF9C8 Q37504121-9F4CDAC6-26FB-4288-A63A-2EBF15056824 Q37613281-2B77B3F3-F99E-4948-806B-B6D7F44FE6B3 Q37683642-1573F630-1C4E-445B-904E-121E2D5ECFC6 Q37914111-DA10478F-B6D7-472B-AEF3-AC2830117B1A Q37958864-CF55CC1D-26E9-4784-9838-2CDECAC9569D Q38102732-5890A5A8-79EE-4037-9E49-34E0256B9C63

P2860

Liquid chromatography-mass spectrometry-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated with the progression of nonalcoholic fatty liver disease.

Item

http://www.wikidata.org/entity/Q34103693

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu